<DOC>
	<DOC>NCT00992862</DOC>
	<brief_summary>The purpose of this study is to compare the relative bioavailability of Moexipril HCl 15mg tablets (by Paddock Laboratories, Inc.) with that of UnivascÂ® 15mg tablets (by Schwarz Pharma) following a single oral dose (1 x 15mg tablet) in healthy, adult subjects under fasting conditions.</brief_summary>
	<brief_title>A Relative Bioavailability Study of Moexipril HCl 15 mg Tablets Under Fasting Conditions</brief_title>
	<detailed_description />
	<mesh_term>Moexipril</mesh_term>
	<criteria>Good health as determined by lack of clinically significant abnormalities in health assessment performed at screening Positive test results for HIV or Hepatitis B or C History of allergy or sensitivity to Moexipril HCl or related drugs</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2009</verification_date>
</DOC>